Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Change in Accured Expenses: 2010-2024

Historic Change in Accured Expenses for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to $5.7 million.

  • EyePoint Pharmaceuticals' Change in Accured Expenses rose 160.98% to $2.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.9 million, marking a year-over-year increase of 673.08%. This contributed to the annual value of $5.7 million for FY2024, which is 277.29% up from last year.
  • As of FY2024, EyePoint Pharmaceuticals' Change in Accured Expenses stood at $5.7 million, which was up 277.29% from $1.5 million recorded in FY2023.
  • In the past 5 years, EyePoint Pharmaceuticals' Change in Accured Expenses ranged from a high of $8.5 million in FY2021 and a low of $1.2 million during FY2022.
  • For the 3-year period, EyePoint Pharmaceuticals' Change in Accured Expenses averaged around $2.8 million, with its median value being $1.5 million (2023).
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Change in Accured Expenses skyrocketed by 352.78% in 2021 and then crashed by 85.87% in 2022.
  • Over the past 5 years, EyePoint Pharmaceuticals' Change in Accured Expenses (Yearly) stood at $1.9 million in 2020, then spiked by 352.78% to $8.5 million in 2021, then crashed by 85.87% to $1.2 million in 2022, then grew by 26.79% to $1.5 million in 2023, then soared by 277.29% to $5.7 million in 2024.